Given the central role of HMG-CoA reductase in regulating cholesterol biosynthesis and its involvement in the development of atherosclerosis and cardiovascular disease [88,94], the strong binding affinities observed in silico for these phytochemicals highlight their considerable therapeutic potential. The gene discussed is HMGCR; the disease is atherosclerosis.